MicroRNA expression signatures and their correlation with clinicopathological features in glioblastoma multiforme

NeuroMolecular Medicine

Volumn 16, Issue 3, 2014, Pages 565-577

  Henriksen, Michael ^a   Johnsen, Kasper Bendix ^a   Olesen, Pia ^a,b   Pilgaard, Linda ^a   Duroux, Meg ^a  

^a AALBORG UNIVERSITY   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Clinicopathological data; Exosome; Glioblastoma multiforme; miR 125b; miRNA signatures; Nestin; Survival

Indexed keywords

MICRORNA; RNA; TRANSCRIPTOME; TUMOR PROTEIN;

ADULT; AGED; BIOSYNTHESIS; BRAIN TUMOR; CELL MOTION; EXOSOME; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GLIOBLASTOMA; HUMAN; KAPLAN MEIER METHOD; MALE; MESODERM; METABOLISM; MIDDLE AGED; MORTALITY; PARACRINE SIGNALING; PHYSIOLOGY; PROGNOSIS; RISK; TUMOR GENE; TUMOR INVASION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CELL MOVEMENT; EXOSOMES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GLIOBLASTOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MESODERM; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PARACRINE COMMUNICATION; PROGNOSIS; RISK; RNA, NEOPLASM; TRANSCRIPTOME;

EID: 84906095884     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-014-8309-7     Document Type: Article

References (63)

1. Bartel, D. P. (2009). MicroRNAs: Target recognition and regulatory functions. Cell, 136(2), 215-233. doi: 10.1016/j.cell.2009.01.002.
2. Chaudhry, N. S., Shah, A. H., Ferraro, N., Snelling, B. M., Bregy, A., Madhavan, K., et al. (2013). Predictors of long-term survival in patients with glioblastoma multiforme: Advancements from the last quarter century. Cancer Investigation, 31(5), 287-308. doi: 10.3109/07357907.2013.789899.
3. Chen, L., et al. (2013). Epigenetic regulation of connective tissue growth factor by microRNA-214 delivery in exosomes from mouse or human hepatic stellate cells. Hepatology (Baltimore, MD). doi: 10.1002/hep.26768.
4. Cui, J. G., Zhao, Y., Sethi, P., Li, Y. Y., Mahta, A., Culicchia, F., et al. (2010). Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation. Journal of Neuro-Oncology, 98(3), 297-304. doi: 10.1007/s11060-009-0077-0.
5. Cui, Y., Xiao, Z., Han, J., Sun, J., Ding, W., Zhao, Y., et al. (2012). MiR-125b orchestrates cell proliferation, differentiation and migration in neural stem/progenitor cells by targeting Nestin. BMC Neuroscience, 13, 116. doi: 10.1186/1471-2202-13-116.
6. Dahlrot, R. H., Hermansen, S. K., Hansen, S., & Kristensen, B. W. (2013). What is the clinical value of cancer stem cell markers in gliomas? International Journal of Clinical and Experimental Pathology, 6(3), 334-348.
7. Dolecek, T. A., Propp, J. M., Stroup, N. E., & Kruchko, C. (2012). CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro-oncology, 14(Suppl 5), v1-v49. doi: 10.1093/neuonc/nos218.
8. Dunning, M. J., Smith, M. L., Ritchie, M. E., & Tavaré, S. (2007). beadarray: R classes and methods for Illumina bead-based data. Bioinformatics, 23(16), 2183-2184. doi: 10.1093/bioinformatics/btm311.
9. EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013). Extracellular vesicles: Biology and emerging therapeutic opportunities. Nature Reviews Drug Discovery. doi: 10.1038/nrd3978.
10. Ernst, A., Campos, B., Meier, J., Devens, F., Liesenberg, F., Wolter, M., et al. (2010). De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures. Oncogene, 29(23), 3411-3422. doi: 10.1038/onc.2010.83.
11. Henriksen, M., Johnsen, K. B., Andersen, H. H., Pilgaard, L., & Duroux, M. (2014). MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme - A systematic overview. Molecular Neurobiology. doi: 10.1007/s12035-014-8668-y.
12. Hermansen, S. K., Christensen, K. G., Jensen, S. S., & Kristensen, B. W. (2011). Inconsistent immunohistochemical expression patterns of four different CD133 antibody clones in glioblastoma. The Journal of Histochemistry and Cytochemistry, 59(4), 391-407. doi: 10.1369/0022155411400867.
13. Hombach-Klonisch, S., Paranjothy, T., Wiechec, E., Pocar, P., Mustafa, T., Seifert, A., et al. (2008). Cancer stem cells as targets for cancer therapy: Selected cancers as examples. Archivum Immunologiae et Therapiae Experimentalis, 56(3), 165-180. doi: 10.1007/s00005-008-0023-4.
14. Hsu, S.-D., et al. (2011). miRTarBase: A database curates experimentally validated microRNA-target interactions. Nucleic Acids Research, 39(Database issue), D163-D169. doi: 10.1093/nar/gkq1107.
15. Huang, L., Luo, J., Cai, Q., Pan, Q., Zeng, H., Guo, Z., et al. (2011). MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. International Journal of Cancer, 128(8), 1758-1769. doi: 10.1002/ijc.25509.
16. Ishiwata, T., Matsuda, Y., & Naito, Z. (2011). Nestin in gastrointestinal and other cancers: Effects on cells and tumor angiogenesis. World Journal of Gastroenterology: WJG, 17(4), 409-418. doi: 10.3748/wjg.v17.i4.409.
17. Jin, Z., Xu, S., Yu, H., Yang, B., Zhao, H., & Zhao, G. (2013). miR-125b inhibits Connexin43 and promotes glioma growth. Cellular and Molecular Neurobiology, 33(8), 1143-1148. doi: 10.1007/s10571-013-9980-1.
18. Kanu, O. O., Mehta, A., Di, C., Lin, N., Bortoff, K., Bigner, D. D., et al. (2009). Glioblastoma multiforme: A review of therapeutic targets. Expert Opinion on Therapeutic Targets, 13(6), 701-718. doi: 10.1517/14728220902942348.
19. Katakowski, M., Buller, B., Wang, X., Rogers, T., & Chopp, M. (2010). Functional microRNA is transferred between glioma cells. Cancer Research, 70(21), 8259-8263. doi: 10.1158/0008-5472.CAN-10-0604.
20. Katakowski, M., Buller, B., Zheng, X., Lu, Y., Rogers, T., Osobamiro, O., et al. (2013). Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Letters, 335(1), 201-204. doi: 10.1016/j.canlet.2013.02. 019.
21. Kucharzewska, P., Christianson, H. C., Welch, J. E., Svensson, K. J., Fredlund, E., Ringnér, M., et al. (2013). Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proceedings of the National Academy of Sciences of the United States of America, 110(18), 7312-7317. doi: 10.1073/pnas. 1220998110.
22. Lagos-Quintana, M. (2001). Identification of novel genes coding for small expressed RNAs. Science (New York, NY), 294(5543), 853-858. doi: 10.1126/science.1064921.
23. Lakomy, R., Sana, J., Hankeova, S., Fadrus, P., Kren, L., Lzicarova, E., et al. (2011). MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients. Cancer Science, 102(12), 2186-2190. doi: 10.1111/j.1349-7006.2011.02092.x.
24. Li, C. C., Eaton, S. A., Young, P. E., Lee, M., Shuttleworth, R., Humphreys, D. T., et al. (2013a). Glioma microvesicles carry selectively packaged coding and non-coding RNAs which alter gene expression in recipient cells. RNA Biology, 10(8), 1333-1344. doi: 10.4161/rna.25281.
25. Li, Y., Xu, J., Chen, H., Bai, J., Li, S., Zhao, Z., et al. (2013b). Comprehensive analysis of the functional microRNA-mRNA regulatory network identifies miRNA signatures associated with glioma malignant progression. Nucleic Acids Research, 41(22), e203. doi: 10.1093/nar/gkt1054.
26. Lima, F. R. S., Kahn, S. A., Soletti, R. C., Biasoli, D., Alves, T., da Fonseca, A. C. C., et al. (2012). Glioblastoma: Therapeutic challenges, what lies ahead. Biochimica et Biophysica Acta, 1826(2), 338-349. doi: 10.1016/j.bbcan.2012.05.004.
27. Lu, W. J., Lan, F., He, Q., Lee, A., Tang, C. Z., Dong, L., et al. (2011). Inducible expression of stem cell associated intermediate filament nestin reveals an important role in glioblastoma carcinogenesis. International Journal of Cancer, 128(2), 343-351. doi: 10.1002/ijc.25586.
28. Malzkorn, B., et al. (2010). Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathology (Zurich, Switzerland), 20(3), 539-550. doi: 10.1111/j.1750-3639. 2009.00328.x.
29. Manterola, L., Guruceaga, E., Pérez-Larraya, J. G., González-Huarriz, M., Jauregui, P., Tejada, S., et al. (2014). A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool. Neuro-oncology, 16(4), 520-527. doi: 10.1093/neuonc/not218.
30. Møller, H. G., Rasmussen, A. P., Andersen, H. H., Johnsen, K. B., Henriksen, M., & Duroux, M. (2013). A systematic review of microRNA in glioblastoma multiforme: Micro-modulators in the mesenchymal mode of migration and invasion. Molecular Neurobiology, 47(1), 131-144. doi: 10.1007/s12035-012- 8349-7.
31. Noerholm, M., Balaj, L., Limperg, T., Salehi, A., Zhu, L. D., Hochberg, F. H., et al. (2012). RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer, 12, 22. doi: 10.1186/1471-2407-12-22.
32. Ohno, S.-I., Takanashi, M., Sudo, K., Ueda, S., Ishikawa, A., Matsuyama, N., et al. (2012). Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Molecular Therapy. doi: 10.1038/mt.2012.180.
33. Pan, Q., Ramakrishnaiah, V., Henry, S., Fouraschen, S., de Ruiter, P. E., Kwekkeboom, J., et al. (2012). Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi). Gut, 61(9), 1330-1339. doi: 10.1136/gutjnl-2011-300449.
34. Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., et al. (2012). Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nature Medicine, 18(6), 883-891. doi: 10.1038/nm.2753.
35. Rak, J., & Guha, A. (2012). Extracellular vesicles-vehicles that spread cancer genes. BioEssays: News and reviews in molecular, cellular and developmental biology, 34(6), 489-497. doi: 10.1002/bies.201100169.
36. Record, M., Subra, C., Silvente-Poirot, S., & Poirot, M. (2011). Exosomes as intercellular signalosomes and pharmacological effectors. Biochemical Pharmacology, 81(10), 1171-1182. doi: 10.1016/j.bcp.2011.02.011.
37. Sharma, S., Das, K., Woo, J., & Gimzewski, J. K. (2014). Nanofilaments on glioblastoma exosomes revealed by peak force microscopy. Journal of the Royal Society, Interface/the Royal Society, 11(92), 20131150. doi: 10.1098/rsif.2013.1150.
38. Shi, L., Zhang, J., Pan, T., Zhou, J., Gong, W., Liu, N., et al. (2010). MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation. Brain Research, 1312, 120-126. doi: 10.1016/j.brainres.2009.11. 056.
39. Shi, L., Wan, Y., Sun, G., Gu, X., Qian, C., Yan, W., et al. (2012). Functional differences of miR-125b on the invasion of primary glioblastoma CD133-negative cells and CD133-positive cells. Neuromolecular Medicine, 14(4), 303-316. doi: 10.1007/s12017-012-8188-8.
40. Shi, L., Wan, Y., Sun, G., Zhang, S., Wang, Z., & Zeng, Y. (2013). miR-125b inhibitor may enhance the invasion-prevention activity of temozolomide in glioblastoma stem cells by targeting PIAS3. BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals And Gene Therapy. doi: 10.1007/s40259-013-0053-2.
41. Sidhu, S. S., Mengistab, A. T., Tauscher, A. N., LaVail, J., & Basbaum, C. (2004). The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions. Oncogene, 23(4), 956-963. doi: 10.1038/sj.onc.1207070.
42. Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., et al. (2004). Identification of human brain tumour initiating cells. Nature, 432(7015), 396-401. doi: 10.1038/nature03128.
43. Skog, J., Würdinger, T., Van Rijn, S., Meijer, D. H., Gainche, L., Sena-Esteves, M., et al. (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nature Cell Biology, 10(12), 1470-1476. doi: 10.1038/ncb1800.
44. Smits, M., Wurdinger, T., van het Hof, B., Drexhage, J. A. R., Geerts, D., Wesseling, P., et al. (2012). Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 26(6), 2639-2647. doi: 10.1096/fj.11-202820.
45. Stieber, D., Golebiewska, A., Evers, L., Lenkiewicz, E., Brons, N. H. C., Nicot, N., et al. (2014). Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes. Acta Neuropathologica, 127(2), 203-219. doi: 10.1007/s00401-013- 1196-4.
46. Talasila, K. M., Soentgerath, A., Euskirchen, P., Rosland, G. V., Wang, J., Huszthy, P. C., et al. (2013). EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis. Acta Neuropathologica, 125(5), 683-698. doi: 10.1007/s00401-013-1101-1.
47. Tomita, T., Akimoto, J., Haraoka, J., & Kudo, M. (2013). Clinicopathological significance of expression of nestin, a neural stem/progenitor cell marker, in human glioma tissue. Brain Tumor Pathology, 1-10 doi: 10.1007/s10014-013-0169-6.
48. Tunca, B., Tezcan, G., Cecener, G., Egeli, U., Ak, S., Malyer, H., et al. (2012). Olea europaea leaf extract alters microRNA expression in human glioblastoma cells. Journal of Cancer Research and Clinical Oncology, 138(11), 1831-1844. doi: 10.1007/s00432-012-1261-8.
49. Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., et al. (2010). Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell, 17(1), 98-110. doi: 10.1016/j.ccr.2009.12.020.
50. Villarroya-Beltri, C., Gutiérrez-Vázquez, C., Sánchez-Cabo, F., Pérez-Hernández, D., Vázquez, J., Martin-Cofreces, N., et al. (2013). Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nature communications, 4, 2980. doi: 10.1038/ncomms3980.
51. Vlassov, A. V., Magdaleno, S., Setterquist, R., & Conrad, R. (2012). Exosomes: Current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochimica et Biophysica Acta, 1820(7), 940-948. doi: 10.1016/j.bbagen.2012.03.017.
52. Wan, Y., Fei, X.-F., Wang, Z.-M., Jiang, D.-Y., Chen, H.-C., Yang, J., et al. (2012). Expression of miR-125b in the new, highly invasive glioma stem cell and progenitor cell line SU3. Chinese Journal of Cancer, 31(4), 207-214. doi: 10.5732/cjc.011.10336.
53. Wan, Y., Sun, G., Wang, Z., Guo, J., & Shi, L. (2013a). miR-125b promotes cell proliferation by directly targeting Lin28 in glioblastoma stem cells with low expression levels of miR-125b. Neuroreport. doi: 10.1097/WNR.0000000000000085.
54. Wan, Y., Sun, G., Zhang, S., Wang, Z., & Shi, L. (2013b). MicroRNA-125b inhibitor sensitizes human primary glioblastoma cells to chemotherapeutic drug temozolomide on invasion. In Vitro Cellular and Developmental Biology. Animal, 49(8), 599-607. doi: 10.1007/s11626-013-9644-y.
55. Wang, Zheng., Bao, Z., Yan, W., You, G., Wang, Y., Li, X., et al. (2013). Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type. Journal of Experimental & Clinical Cancer Research: CR, 32(1), 59. doi: 10.1186/1756-9966-32-59.
56. Wiese, C., Rolletschek, A., Kania, G., Blyszczuk, P., Tarasov, K. V., Tarasova, Y., et al. (2004). Nestin expression - A property of multi-lineage progenitor cells? Cellular and Molecular Life Sciences, 61(19-20), 2510-2522. doi: 10.1007/s00018-004-4144-6.
57. Winter, J., Jung, S., Keller, S., Gregory, R. I., & Diederichs, S. (2009). Many roads to maturity: MicroRNA biogenesis pathways and their regulation. Nature Cell Biology, 11(3), 228-234. doi: 10.1038/ncb0309-228.
58. Witwer, K. W., Buzás, E. I., Bemis, L. T., Bora, A., Lässer, C., Lötvall, J., et al. (2013). Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. Journal of Extracellular Vesicles, 2, 18389. doi: 10.1074/jbc.M111.277061.
59. Wu, N., Xiao, L., Zhao, X., Zhao, J., Wang, J., Wang, F., et al. (2012). miR-125b regulates the proliferation of glioblastoma stem cells by targeting E2F2. FEBS Letters, 586(21), 3831-3839. doi: 10.1016/j.febslet.2012.08.023.
60. Wu, N., Lin, X., Zhao, X., Zheng, L., Xiao, L., Liu, J., et al. (2013). MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways. British Journal of Cancer, 109(11), 2853-2863. doi: 10.1038/bjc.2013.672.
61. Xia, H.-F., He, T.-Z., Liu, C.-M., Cui, Y., Song, P.-P., Jin, X.-H., et al. (2009). MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 23(4-6), 347-358. doi: 10.1159/000218181.
62. Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., et al. (2009). IDH1 and IDH2 mutations in gliomas. New England Journal of Medicine, 360(8), 765-773. doi: 10.1056/NEJMoa0808710.
63. Zhong, J., Paul, A., Kellie, S. J., & O'Neill, G. M. (2010). Mesenchymal migration as a therapeutic target in glioblastoma. Journal of Oncology, 2010, 430142. doi: 10.1155/2010/430142.